Detoxification of 6-hydroxydopamine-induced Parkinsonian neurodegeneration by G-CYPMPO, a novel radical trapper
► We synthesized G-CYPMPO as a novel DEPMPO-type spin trap agent. ► G-CYPMPO may be a more practically useful spin trap agent than other agents. ► G-CYPMPO protected against 6-OHDA-induced nigral neurodegeneration. ► Its use could expand the versatility of the biological oxygen radical research. ► G...
Gespeichert in:
Veröffentlicht in: | Neurochemistry international 2011-05, Vol.58 (6), p.721-727 |
---|---|
Hauptverfasser: | , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | ► We synthesized G-CYPMPO as a novel DEPMPO-type spin trap agent. ► G-CYPMPO may be a more practically useful spin trap agent than other agents. ► G-CYPMPO protected against 6-OHDA-induced nigral neurodegeneration. ► Its use could expand the versatility of the biological oxygen radical research. ► G-CYPMPO may be useful for in oxidative stress-mediated disorders including PD.
2-(5,5-Dimethyl-2-oxo-2-λ
5-[1,3,2]dioxaphosphinan-2-yl)-2-methyl-3,4-dihydro-2
H-pyrroline
N-oxide {2-(5,5-dimethyl-2-oxo-1,3,2-dioxaphosphinan-2-yl)-3,4-dihydro-2-methyl-2
H-pyrrole
N-oxide, G-CYPMPO} as the stable crystals having gauche conformation was successfully synthesized as a novel 5-diethoxyphosphoryl-5-methyl-1-pyrroline
N-oxide (DEPMPO)-type spin trap agent. However, the function of G-CYPMPO
in vivo is still unclear. Thus, the purpose of this study was to evaluate the effects of G-CYPMPO in an
in vivo model of Parkinson's disease (PD). Rats were microinjected with 6-hydroxydopamine (6-OHDA, 32
nmol) in the presence or absence of G-CYPMPO (0.4, 1.2, 4
nmol). We investigated behavioral and histochemical parameters in this rat model of PD. In addition, to examine the effects of G-CYPMPO against oxidative stress, we used electron spin resonance (ESR) spectrometry. Intranigral injection of 6-OHDA alone induced a massive loss of tyrosine hydroxylase (TH)-positive neurons in the substantia nigra pars compacta (SNpc). Co-microinjection of G-CYPMPO significantly prevented 6-OHDA-induced dopaminergic neurodegeneration and behavioral impairments. Immunoreactivities for glial markers, such as cluster of differentiation antigen-11b (CD11b) and glial fibrillary acidic protein (GFAP), were notably detected in the SNpc of rats injected with 6-OHDA alone. These immunoreactivities were markedly suppressed by the co-microinjection of G-CYPMPO, similar to the results in vehicle-treated rats. In addition, G-CYPMPO directly trapped hydroxyl radical (
OH) generated from 6-OHDA and Fe
2+ in a concentration-dependent manner. These results suggest that G-CYPMPO attenuates 6-OHDA-induced dopaminergic neurodegeneration in a rat model of PD, and is a useful tool for biological research. |
---|---|
ISSN: | 0197-0186 1872-9754 |
DOI: | 10.1016/j.neuint.2011.02.013 |